CLVLF
Price
$8.50
Change
+$0.54 (+6.78%)
Updated
Aug 27 closing price
Capitalization
407.93M
MDWD
Price
$16.82
Change
-$0.18 (-1.06%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
182.93M
82 days until earnings call
Interact to see
Advertisement

CLVLF vs MDWD

Header iconCLVLF vs MDWD Comparison
Open Charts CLVLF vs MDWDBanner chart's image
Clinuvel Pharmaceuticals
Price$8.50
Change+$0.54 (+6.78%)
Volume$500
Capitalization407.93M
MediWound
Price$16.82
Change-$0.18 (-1.06%)
Volume$3.94K
Capitalization182.93M
CLVLF vs MDWD Comparison Chart in %
Loading...
CLVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLVLF vs. MDWD commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLVLF is a StrongBuy and MDWD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CLVLF: $8.50 vs. MDWD: $17.00)
Brand notoriety: CLVLF and MDWD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLVLF: 181% vs. MDWD: 182%
Market capitalization -- CLVLF: $407.93M vs. MDWD: $182.93M
CLVLF [@Biotechnology] is valued at $407.93M. MDWD’s [@Biotechnology] market capitalization is $182.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLVLF’s FA Score shows that 1 FA rating(s) are green whileMDWD’s FA Score has 1 green FA rating(s).

  • CLVLF’s FA Score: 1 green, 4 red.
  • MDWD’s FA Score: 1 green, 4 red.
According to our system of comparison, CLVLF is a better buy in the long-term than MDWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLVLF’s TA Score shows that 4 TA indicator(s) are bullish while MDWD’s TA Score has 4 bullish TA indicator(s).

  • CLVLF’s TA Score: 4 bullish, 3 bearish.
  • MDWD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CLVLF is a better buy in the short-term than MDWD.

Price Growth

CLVLF (@Biotechnology) experienced а +6.80% price change this week, while MDWD (@Biotechnology) price change was -2.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

MDWD is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLVLF($408M) has a higher market cap than MDWD($183M). CLVLF YTD gains are higher at: 0.562 vs. MDWD (-4.494). CLVLF has higher annual earnings (EBITDA): 63.4M vs. MDWD (-30.62M). CLVLF has more cash in the bank: 184M vs. MDWD (32.4M). CLVLF has less debt than MDWD: CLVLF (880K) vs MDWD (8.07M). CLVLF has higher revenues than MDWD: CLVLF (91.6M) vs MDWD (19.9M).
CLVLFMDWDCLVLF / MDWD
Capitalization408M183M223%
EBITDA63.4M-30.62M-207%
Gain YTD0.562-4.494-13%
P/E Ratio18.22N/A-
Revenue91.6M19.9M460%
Total Cash184M32.4M568%
Total Debt880K8.07M11%
FUNDAMENTALS RATINGS
CLVLF vs MDWD: Fundamental Ratings
CLVLF
MDWD
OUTLOOK RATING
1..100
9452
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4599
PRICE GROWTH RATING
1..100
5564
P/E GROWTH RATING
1..100
924
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLVLF's Valuation (3) in the null industry is somewhat better than the same rating for MDWD (67) in the Pharmaceuticals Other industry. This means that CLVLF’s stock grew somewhat faster than MDWD’s over the last 12 months.

CLVLF's Profit vs Risk Rating (100) in the null industry is in the same range as MDWD (100) in the Pharmaceuticals Other industry. This means that CLVLF’s stock grew similarly to MDWD’s over the last 12 months.

CLVLF's SMR Rating (45) in the null industry is somewhat better than the same rating for MDWD (99) in the Pharmaceuticals Other industry. This means that CLVLF’s stock grew somewhat faster than MDWD’s over the last 12 months.

CLVLF's Price Growth Rating (55) in the null industry is in the same range as MDWD (64) in the Pharmaceuticals Other industry. This means that CLVLF’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's P/E Growth Rating (4) in the Pharmaceuticals Other industry is significantly better than the same rating for CLVLF (92) in the null industry. This means that MDWD’s stock grew significantly faster than CLVLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLVLFMDWD
RSI
ODDS (%)
Bearish Trend 2 days ago
32%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 17 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
39%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CLVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWTIX21.310.09
+0.42%
Virtus Duff & Phelps Water Inst
FZAJX22.80N/A
N/A
Fidelity Advisor International Growth Z
MASOX10.74N/A
N/A
MoA Small Cap Equity Index Fund
FEREX12.12N/A
N/A
First Eagle Global Real Assets I
FSMVX30.99N/A
N/A
Fidelity Mid Cap Value

CLVLF and

Correlation & Price change

A.I.dvisor tells us that CLVLF and IONS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLF and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLF
1D Price
Change %
CLVLF100%
+6.80%
IONS - CLVLF
24%
Poorly correlated
+1.38%
PXXLF - CLVLF
23%
Poorly correlated
N/A
NICXF - CLVLF
22%
Poorly correlated
N/A
RVMD - CLVLF
21%
Poorly correlated
+2.05%
MDWD - CLVLF
21%
Poorly correlated
+0.95%
More